Seguimos Avanzando - Latino Youth Coping With Discrimination

Latino Youth Coping With Discrimination: A Multi-Level Investigation in Micro- and Macro-Time

The overall objective of this study is to investigate mediators and moderators at multiple ecological (individual, family/peer and school/neighborhood levels) and time-scale (micro- and macro-time) levels in the link between discrimination-related stressors and mental health among 340 Mexican-origin youth.

Study Overview

• Status: Completed
• Conditions: Mental Health

Detailed Description

The project's long-term goal is to improve the mental health of Mexican-origin youth by reducing the deleterious effects of racism, "othering," and negative neighborhood interactions. Community based collaboration will be used to recruit a sample of 340 Mexican-origin adolescents, mothers, and fathers in Indiana. The inclusion of fathers will be a valuable contribution to the literature, given the dearth of studies on Latinx fathers/stepfathers. A combination of annual surveys administered over three waves to parents and youth ("macro-time") and a 21-day daily diary ("micro-time") administered in wave 1 to youth is employed to assess important questions about how mediating and moderating processes unfold over time. Specific aims of the project include determination of within-person discrimination-related stressors that impact youth's mental health outcomes and the mechanisms of action at both micro- and macro- time levels; identification of protective factors that could help coping with discrimination related stressors and conditions under which they work; and elucidating youth, parent, and neighborhood risk factors that moderate the link between discrimination-related stressors and mental health outcomes in youth. This research is highly translational in that it will facilitate the development of more effective, culturally sensitive prevention and intervention strategies for Latinx youth and their families.

• Study Type: Observational
• Enrollment (Actual): 886

Contacts and Locations

Study Locations

• United States
  • Indiana
    • South Bend, Indiana, United States, 46635
      • University of Notre Dame, William J. Shaw Center for Children and Families

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 12 years and older (Child, Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

• Mexican descent adolescents between the ages of 12-15 years old (at enrollment)
• Mexican-Origin caregivers over the age of 18

Description

Inclusion Criteria:

Adolescent Inclusion Criteria:

• The adolescent has two eligible caregivers (as defined in the following criteria)
• The adolescent resides with at least one of the two caregivers.
• One of the caregivers is a parent or legal guardian who is eligible to give consent for the child's participation.

Caregiver Inclusion Criteria:

• Biological Parents of Mexican origin
• Legal guardians of Mexican origin
• Step-parents of Mexican origin
• A caregiver of Mexican origin identified by the parent/guardian who is 18 or older (e.g., grandparents, uncles/aunts, older siblings, godparents)

Exclusion Criteria:

• A parent reports that the adolescent has a severe learning or developmental disability which would prevent understanding/survey response

Study Plan

How is the study designed?

Design Details

• Observational Models: Other
• Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Children's Depression Inventory 2nd Edition™: Self-Report Short Form [(CDI-2: SR(S)]	Youth Depression, Total score 0-24, Higher scores are worse	Time 0 (baseline)
Children's Depression Inventory 2nd Edition™: Self-Report Short Form [(CDI-2: SR(S)]	Youth Depression, Total score 0-24, Higher scores are worse	Month 12
Children's Depression Inventory 2nd Edition™: Self-Report Short Form [(CDI-2: SR(S)]	Youth Depression, Total score 0-24, Higher scores are worse	Month 24
Screen for Child Anxiety Related Disorders/ [General Anxiety subscale only] (SCARED)	Youth Anxiety, Subscale Total score 0-18, Higher scores are worse	Time 0 (baseline)
Screen for Child Anxiety Related Disorders/ [General Anxiety subscale only] (SCARED)	Youth Anxiety, Subscale Total score 0-18, Higher scores are worse	Month 12
Screen for Child Anxiety Related Disorders/ [General Anxiety subscale only] (SCARED)	Youth Anxiety, Subscale Total score 0-18, Higher scores are worse	Month 24
Youth Self-Report for Ages 11-18 (YSR/11-18)	Youth Psychological Symptoms	Time 0 (baseline)
Youth Self-Report for Ages 11-18 (YSR/11-18)	Youth Psychological Symptoms	Month 12
Youth Self-Report for Ages 11-18 (YSR/11-18)	Youth Psychological Symptoms	Month 24
Child Behavior Checklist for Ages 6-18 (CBCL/6-18)	Adaptive Functioning	Time 0 (baseline)
Child Behavior Checklist for Ages 6-18 (CBCL/6-18)	Adaptive Functioning	Month 12
Child Behavior Checklist for Ages 6-18 (CBCL/6-18)	Adaptive Functioning	Month 24
Pittsburgh Sleep Quality Index (PSQI)	Sleep Duration and Quality; Total global score (for unadapted scale) 0-21	Time 0 (baseline)
Pittsburgh Sleep Quality Index (PSQI)	Sleep Duration and Quality; Total global score (for unadapted scale) 0-21	Month 12
Pittsburgh Sleep Quality Index (PSQI)	Sleep Duration and Quality; Total global score (for unadapted scale) 0-21	Month 24

Collaborators and Investigators

• Sponsor: Massachusetts General Hospital
• Collaborators: Indiana University; University of Notre Dame; Fordham University

Study record dates

Study Major Dates

• Study Start (Actual): April 9, 2021
• Primary Completion (Actual): October 11, 2024
• Study Completion (Actual): October 11, 2024

Study Registration Dates

• First Submitted: April 9, 2021
• First Submitted That Met QC Criteria: May 4, 2021
• First Posted (Actual): May 6, 2021

Study Record Updates

• Last Update Posted (Actual): November 29, 2024
• Last Update Submitted That Met QC Criteria: November 26, 2024
• Last Verified: November 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: 2020P001721

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No